From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
April 19, 2016
Philadelphia, PA, April 19, 2016 – IntegriChain, a rapidly growing cloud software company focused on channel management for life sciences suppliers, today announced the launch of Specialty Pharmacy Index, a new data service for life sciences manufacturers that identifies gaps in patient access for specialty pharmaceuticals and targets the best ways to address them. This cross-industry, real-world data service also helps shape product- or class-specific specialty distribution strategies and identify the most qualified pharmacies to enhance provider experience, patient adherence, and therapeutic outcomes.
“Developing a winning specialty channel design is critical now and can be quite challenging as life sciences manufacturers must rely on new data sources for business intelligence to maximize outcomes for the brand and to maintain positive patient access,” said David Weiss, IntegriChain Executive Director of Solutions. “Our Specialty Pharmacy Index overcomes these challenges by providing manufacturers with 100% visibility to the downstream specialty providers. By enriching the datasets with competitive market basket performance data, channel strategists and marketers can see the share of the overall national or regional marketplace each specialty pharmacy manages. Additionally, by providing regular updates to the Index, manufacturers have a clear line of sight into the trends and performance of their network over time and, more importantly, have empirical diagnostic tools to pinpoint underlying issues.”
With Specialty Pharmacy Index, life sciences manufacturers can:
IntegriChain will demonstrate Specialty Pharma Index at ARMADA Specialty Pharmacy Summit 2016, May 2-6, in Las Vegas.
About IntegriChain IntegriChain is the leading channel management cloud used by life sciences suppliers, including nine of the top-10 pharmaceutical manufacturers, to drive channel collaboration and to improve the efficiency of how products reach customers. Pharmaceutical, biopharm/specialty pharma, generics, and consumer health suppliers use IntegriChain to manage their supply chain relationships, inventories, and orders across a vast network of retailers, ecommerce, and distributors. As a suite of informed applications and analytics built on top of aggregated channel inventory and point-of-sale (POS) data, IntegriChain provides customer operations, national accounts, and finance teams with a collaborative, agile, and mobile alternative to ERP and homegrown systems. By embedding big-data customer insights into daily business processes, IntegriChain helps control the high cost of product distribution while improving product availability, ensuring a higher level of revenue predictability and maximizing distribution investment. More than $200 billion in annual U.S. commerce and two billion transactions flow through the IntegriChain Cloud annually. IntegriChain is backed by Accel-KKR, a leading technology private equity firm. For more information, visit www.integrichain.com and our blog, and follow us on Twitter @IntegriChain and LinkedIn.
IntegriChain is a registered trademark of IntegriChain Incorporated. All other trademarks are property of their respective owners.
Contacts Jennifer Guinan | Sage Strategic Marketing 610.410.8111 Jennifer@sagestrat.com
Register Now
Webinars & Resources
See List
